Your browser doesn't support javascript.
loading
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia.
Deodato, Marina; Frustaci, Anna Maria; Sportoletti, Paolo; Laurenti, Luca; Murru, Roberta; Visentin, Andrea; Reda, Gianluigi; Mauro, Francesca Romana; Quaresmini, Giulia; Vanazzi, Anna; Vitale, Candida; Orsucci, Lorella; Massaia, Massimo; Sanna, Alessandro; Motta, Marina; Ibatici, Adalberto; Ferrarini, Isacco; Borella, Chiara; Varettoni, Marzia; Tani, Monica; Marinoni, Sara; Ferrario, Andrea; Zamprogna, Giulia; Montillo, Marco; Tedeschi, Alessandra.
Afiliação
  • Deodato M; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Frustaci AM; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Sportoletti P; Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, Italy.
  • Laurenti L; Institute of Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • Murru R; Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, Cagliari, Italy.
  • Visentin A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padova, Padova, Italy.
  • Reda G; U.O.C. Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
  • Mauro FR; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Roma, Italy.
  • Quaresmini G; USC Ematologia, ASST PAPA GIOVANNI XXIII, Bergamo, Italy.
  • Vanazzi A; Division of Clinical Haemato-Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Vitale C; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, Università di Torino, Torino, Italy.
  • Orsucci L; S.C. Ematologia, AOU Città della Salute e della Scienza, Torino, Italy.
  • Massaia M; Hematology Unit, ASO Santa Croce e Carle, Cuneo, Italy.
  • Sanna A; Hematology, Department of Oncology, AOU Careggi, Florence, Italy.
  • Motta M; Hematology Department, ASST Spedali Civili, Brescia, Italy.
  • Ibatici A; Hematology Unit and Bone Marrow Transplantation, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Ferrarini I; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Borella C; Hematology Department, San Gerardo Hospital, ASST Monza, Monza, Italy.
  • Varettoni M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Tani M; U.O.C. di Ematologia Ospedale Santa Maria delle Croci, Ravenna, Italy.
  • Marinoni S; UOC Ematologia, ASST Ovest milanese, Ospedale di Legnano, Legnano, Italy.
  • Ferrario A; UO Ematologia, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy.
  • Zamprogna G; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Montillo M; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Tedeschi A; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Leuk Lymphoma ; 63(8): 1985-1988, 2022 08.
Article em En | MEDLINE | ID: mdl-35343363

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article